PET imaging of acute and chronic inflammation in living mice

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 11, 2007, Pages 1832-1842

  Cao, Qizhen ^a   Cai, Weibo ^a   Li, Zi Bo ^a   Chen, Kai ^a   He, Lina ^a   Li, Hui Cheng ^b   Hui, Mizhou ^b   Chen, Xiaoyuan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AmProtein Corporation   (United States)

Author keywords

Acute and chronic inflammation; Etanercept; Integrin v 3; Positron emission tomography; TNF

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID COPPER 64; BETA3 INTEGRIN; CD51 ANTIGEN; EOSIN; ETANERCEPT; HEMATOXYLIN; PHORBOL 13 ACETATE 12 MYRISTATE; TRACER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CHRONIC INFLAMMATION; CONTROLLED STUDY; EX VIVO STUDY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; OTITIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION;

ANIMALS; COPPER RADIOISOTOPES; IMMUNOGLOBULIN G; INFLAMMATION; INTEGRIN ALPHAVBETA3; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, TUMOR NECROSIS FACTOR; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35348945922     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0451-0     Document Type: Article

References (39)

1. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci 1997;2:d12-26.
2. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005;12:255-69.
3. Franquet T, Stern EJ. Bronchiolar inflammatory diseases: high-resolution CT findings with histologic correlation. Eur Radiol 1999;9:1290-303.
4. Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/ inflammation in the new millennium. Eur J Nucl Med 2001;28:241-52.
5. Tehranzadeh J, Ashikyan O, Dascalos J. Magnetic resonance imaging in early detection of rheumatoid arthritis. Semin Musculoskelet Radiol 2003;7:79-94.
6. Lavender JP, Lowe J, Barker JR, Burn JI, Chaudhri MA. Gallium 67 citrate scanning in neoplastic and inflammatory lesions. Br J Radiol 1971;44:361-6.
7. Fischman AJ, Rubin RH, White JA, Locke E, Wilkinson RA, Nedelman M, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med 1990;31:1199-205.
8. 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med 2000;41:622-30.
9. 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet 1986;2:946-9.
10. Becker W, Bair J, Behr T, Repp R, Streckenbach H, Beck H, et al. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. J Nucl Med 1994;35:1436-43.
11. Thakur ML, Marcus CS, Henneman P, Butler J, Sinow R, Diggles L, et al. Imaging inflammatory diseases with neutrophil-specific technetium-99m-labeled monoclonal antibody anti-SSEA-1. J Nucl Med 1996;37:1789-95.
12. van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, Edwards DS, Barrett JA, et al. Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation. J Nucl Med 1997;38:1310-5.
13. Barrera P, van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, van Lent PL, et al. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. Rheumatology (Oxford) 2000;39:870-4.
14. 99mTc-labeled interleukin-8. J Nucl Med 2001;42:117-23.
15. 123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease. J Nucl Med 2000;41:242-9.
16. Moyer BR, Vallabhajosula S, Lister-James J, Bush LR, Cyr JE, Snow DA, et al. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection. J Nucl Med 1996;37:673-9.
17. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000;27:822-32.
18. Leong KG, Karsan A. Signaling pathways mediated by tumor necrosis factor alpha. Histol Histopathol 2000;15:1303-25.
19. Cairns CB, Panacek EA, Harken AH, Banerjee A. Bench to bedside: tumor necrosis factor-alpha: from inflammation to resuscitation. Acad Emerg Med 2000;7:930-41.
20. Taylor PC. Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr Pharm Des 2003;9:1095-106.
21. Goldenberg MM. Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther 1999;21:75-87.
22. Goffe B. Etanercept (Enbrel)-an update. Skin Therapy Lett 2004;9:1-4.
23. 3 antagonism. Anti-Cancer Agents Med Chem 2006;6:407-28.
24. Danese S, Sans M, de la Motte C, Graziani C, West G, Phillips MH, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006;130:2060-73.
25. 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis 2002;61 Suppl 2:ii96-9.
26. 3 antagonist. J Clin Invest 1999;103:47-54.
27. 64Cu-labeled tetrameric RGD peptide. J Nucl Med 2005;46:1707-18.
28. 3. Cancer Res 2006;66:9673-81.
29. Meares CF, McCall MJ, Reardan DT, Goodwin DA, Diamanti CI, McTigue M. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal Biochem 1984;142:68-78.
30. Murakawa M, Yamaoka K, Tanaka Y, Fukuda Y. Involvement of tumor necrosis factor (TNF)-alpha in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice. Biochem Pharmacol 2006;71:1331-6.
31. 3 integrin expression. J Nucl Med 2006;47:1172-80.
32. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med 2006;47:492-501.
33. Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006;6:669-76.
34. Cai W, Rao J, Gambhir SS, Chen X. How molecular imaging is speeding up anti-angiogenic drug development. Mol Cancer Ther 2006;5:2624-33.
35. Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:515-23.
36. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. Faseb J 1997;11:457-65.
37. Walsh DA. Angiogenesis and arthritis. Rheumatology (Oxford) 1999;38:103-12.
38. Cai W, Chen K, Mohamedali KA, Cao Q, Gambhir SS, Rosenblum MG, et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med 2006;47:2048-56.
39. 18F-galacto-RGD. J Nucl Med 2005;46:184-9.